NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Everolimus for preventing organ rejection in liver transplantation - NICE TAG TA348

Everolimus for preventing organ rejection in liver transplantation - NICE TAG TA348

1.1 Everolimus is not recommended within its marketing authorisation for preventing organ rejection in people having a liver transplant.

1.2 People whose treatment with everolimus was started within the NHS before this guidance was published, should be able to continue everolimus until they and their NHS clinician consider it appropriate to stop.

http://www.nice.org.uk/guidance/ta348

Site by Devopa
© Copyright 2019 NHS. All rights reserved.